Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 7;8(3):325.
doi: 10.3390/jcm8030325.

Analysis of the Effectiveness of Lornoxicam and Flurbiprofen on Management of Pain and Sequelae Following Third Molar Surgery: A Randomized, Controlled, Clinical Trial

Gaetano Isola  1 , Angela Alibrandi  2 , Eugenio Pedullà  3 , Vincenzo Grassia  4 , Sebastiano Ferlito  5 , Letizia Perillo  6 , Ernesto Rapisarda  7
Affiliations

Analysis of the Effectiveness of Lornoxicam and Flurbiprofen on Management of Pain and Sequelae Following Third Molar Surgery: A Randomized, Controlled, Clinical Trial

Gaetano Isola et al. J Clin Med. .

Abstract

The aim of this study was to analyze the effectiveness of Lornoxicam and Flurbiprofen in reducing perioperative sequelae after impacted mandibular third molar surgery. Ninety-one patients who needed surgical extraction of an impacted mandibular third molar were selected for the study. All subjects were randomly allocated to receive one of the following treatments twice a day for 5 days after surgery: placebo (n = 29), Flurbiprofen (n = 31), or Lornoxicam (n = 31). The primary outcome was postoperative pain, evaluated using the visual analogue scale (VAS) score at 30 min, 2, 6, 12, 24, 48 h, 7 and 10 days following surgery. The secondary outcomes chosen were changes in postoperative swelling and maximum mouth opening values compared to preoperative ones. Compared to placebo, treatment with Flurbiprofen and Lornoxicam was characterised by an improvement in the primary outcome. Moreover, the treatment with Lornoxicam presented significantly lower median pain scores at 2 h (p < 0.001) and at 6 h (p = 0.016) compared to Flurbiprofen and at 2 h (p < 0.001), 6 h (p = 0.01), and at 24 h (p = 0.018) after surgery compared with placebo. Swelling and maximum mouth opening values were not significantly different between the groups at each follow-up session. This trial demonstrated that treatment with Lornoxicam showed a decrease in the incidence and severity of pain in the first postoperative phase following third molar surgery compared to Flurbiprofen and placebo.

Keywords: Flurbiprofen; Lornoxicam; pain; randomized clinical trial; swelling; third molar surgery; trismus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest in the present study.

Figures

Figure 1
Figure 1
Flowchart of patient recruitment into the study groups.
Figure 2
Figure 2
Median and inter-quartile range of VAS (visual analogue scale) pain intensity score and significance of comparisons between study groups. *, placebo vs Flurbiprofen; §, placebo vs Lornoxicam; #, Flurbiprofen vs Lornoxicam; ns, not significant.
Figure 3
Figure 3
Overall area under the curve (AUC) for the three treatments. p-value < 0.001.
See this image and copyright information in PMC

References

    1. Chugh A., Singh S., Mittal Y., Chugh V. Submucosal injection of dexamethasone and methylprednisolone for the control of postoperative sequelae after third molar surgery: Randomized controlled trial. Int. J. Oral Maxillofac. Surg. 2018;47:228–233. doi: 10.1016/j.ijom.2017.07.009. - DOI - PubMed
    1. Isola G., Matarese M., Ramaglia L., Iorio-Siciliano V., Cordasco G., Matarese G. Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: A randomized, triple-blind, controlled clinical trial. Clin. Oral Investig. 2018:1–11. doi: 10.1007/s00784-018-2690-9. - DOI - PubMed
    1. Rocha-Neto A.M., Nogueira E.F., Borba P.M., Laureano-Filho J.R., Vasconcelos B.C. Application of dexamethasone in the masseter muscle during the surgical removal of lower third molars. J. Craniofac. Surg. 2017;28:e43–e47. doi: 10.1097/SCS.0000000000003188. - DOI - PubMed
    1. Briguglio F., Briguglio E., Briguglio R., Cafiero C., Isola G. Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: A randomized clinical trial. Quintessence Int. 2013;44:231–240. doi: 10.3290/j.qi.a29054. - DOI - PubMed
    1. Genc A., Cakarer S., Yalcin B.K., Kilic B.B., Isler S.C., Keskin C. A comparative study of surgical drain placement and the use of kinesiologic tape to reduce postoperative morbidity after third molar surgery. Clin. Oral Investig. 2019;23:345–350. doi: 10.1007/s00784-018-2442-x. - DOI - PubMed

LinkOut - more resources